From a global point of view, muscles from patients with RYR1 mutations associated with rhabdomyolysis were similar to controls, whereas muscles from XL-MTM patients showed the greatest changes in gene expression, affecting almost all of the transcripts and miRNAs investigated. The gene discussed is RYR1; the disease is rhabdomyolysis.